Showing results (601-610 of 626) with videos related to

Sort By:
Pageof 63
Nature Communications|April 22, 2015
Systematic evaluation of an atomic clock at 2 × 10(-18) total uncertaintyT L Nicholson, S L Campbell, R B Hutson, et al.
Clinical and Experimental Rheumatology|July 29, 2021
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationaleRobert Spiera, Dinesh Khanna, Masataka Kuwana, et al.
Journal of Physical Activity & Health|August 23, 2024
Association of Accelerometer-Measured Physical Activity With College Student Success and RetentionMyra J Bloom, Gladys Y X Chen, Victor R C Gomes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2017
Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung CancerReinhard Büttner, John R Gosney, Birgit Guldhammer Skov, et al.
Development (Cambridge, England)|February 22, 2019
Gene-environment interaction impacts on heart development and embryo survivalJulie L M Moreau, Scott Kesteven, Ella M M A Martin, et al.
QJM : Monthly Journal of the Association of Physicians|December 14, 2017
Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosisG Cooke, I Kamal, M Strengert, et al.
The American Journal of Managed Care|August 18, 2010
Value and the medical home: effects of transformed primary careRichard J Gilfillan, Janet Tomcavage, Meredith B Rosenthal, et al.
Current Issues in Personality Psychology|May 17, 2024
HEXACO personality factors as predictors of physical activity, resting heart rate, body mass index, and healthy lifestyle behaviorsJonathan R Anderson, Myra J Bloom, Wyatt T Broshous, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology studyJohn M S Bartlett, Kenneth J Bloom, Tammy Piper, et al.
Pageof 63